• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 30, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

New biomaterial has potential to repair damaged bone with lower risk of inflammation

Bioengineer by Bioengineer
June 12, 2020
in Science News
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Titan II

Scientists at RCSI University of Medicine and Health Sciences have developed a new biomaterial that has the potential to accelerate bone regeneration by promoting an immune response that encourages repair and lowers the risk of inflammation.

The study, conducted by researchers at RCSI Tissue Engineering Research Group (TERG) and AMBER, the SFI Research Centre for Advanced Materials and BioEngineering Research, is published in Acta Biomaterialia

The researchers have developed a technology that is a combination of nanoparticles and a collagen-based biomaterial called a scaffold, specifically designed by RCSI TERG that can be surgically implanted to aid bone tissue repair. The material allows for the delivery of a microRNA silencer, a molecule capable of influencing the way our cells function.

In laboratory conditions, researchers successfully demonstrated that damaged bone tissue is restored as the particular microRNA delivered by the biomaterial works to increase cells responsible for bone repair. The technology also assists in promoting a pro-repair immune system response, lowering the risk of inflammation and other complications.

“The results of our research are a promising step towards improving health outcomes for patients with fractures that fail to repair naturally or have degenerative bone diseases such as osteoporosis, although further pre-clinical and clinical trials are still required before the technology could be used to treat humans,” said Dr Caroline Curtin, Lecturer in Anatomy and Regenerative Medicine at RCSI.

“We are confident that this biomaterial system will have several potential applications beyond bone repair, as it can be tailored to deliver other therapeutic molecules that address degenerated or diseased tissue in the body. At RCSI Tissue Engineering Research Group, we are exploring these possibilities through the development of similar methods to repair articular joints like the knee and hip, and attempting to apply the microRNA delivery systems to inhibit breast cancer cell growth and other novel research,” said Prof. Fergal O’Brien RCSI Director of Research and Innovation, Professor of Bioengineering and Regenerative Medicine and Deputy Director of the SFI AMBER Centre.

The research, undertaken by first author Dr Irene Mencía Castaño, is supported by Science Foundation Ireland (SFI) Research Frontiers Programme, the Advanced Materials and Bioengineering Research (AMBER) Centre through SFI and the ERC under the European Commission’s Horizon 2020 Framework Programme/ERC grant agreement.

###

About RCSI University of Medicine and Health Sciences

Ranked number one globally for Good Health and Well-being in the Times Higher Education (THE) University Impact Rankings 2020, RCSI University of Medicine and Health Sciences is an international not-for-profit university, with its headquarters in Dublin.

RCSI is exclusively focused on education and research to drive improvements in human health worldwide. It is among the top 250 universities worldwide in the THE World University Rankings (2020) and its research is ranked first in Ireland for citations. RCSI has been awarded Athena Swan Bronze accreditation for positive gender practice in higher education.

Visit the RCSI MyHealth Expert Directory to find the details of our experts across a range of healthcare issues and concerns. Recognising their responsibility to share their knowledge and discoveries to empower people with information that leads them to better health, these clinicians and researchers are willing to engage with the media in their area of expertise.

About AMBER

AMBER (Advanced Materials and BioEngineering Research) is a world-leading SFI Research Centre hosted by Trinity College Dublin, in partnership with CRANN (Centre for Research on Adaptive Nanostructures and Nanodevices) and the Trinity Centre for Biomedical Engineering at Trinity College, RCSI University of Medicine and Health Sciences, University College Cork, NUI Galway, Dublin City University, Tyndall National Institute, University of Limerick and Athlone Institute of Technology. AMBER is a multidisciplinary partnership between leading academics in materials science, bioengineering and industry, working collaboratively to develop new materials and devices for ICT, medical devices, energy and sustainable industrial technology sectors. http://www.ambercentre.ie

Media Contact
Jane Butler
[email protected]

Related Journal Article

http://dx.doi.org/10.1016/j.actbio.2020.03.042

Tags: BiologyBiomedical/Environmental/Chemical EngineeringMedicine/HealthOrthopedic MedicineSurgeryTrauma/Injury
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Newly Launched BIRDBASE Dataset Monitors Ecological Traits of 11,000 Bird Species

September 30, 2025

Pellino Ubiquitin Ligases: Dual Roles in Blood Cancers

September 30, 2025

WGCNA and ceRNA Illuminate Bovine Fat Deposition

September 30, 2025

Revolutionizing Drug Repositioning with Multi-Hop Graphs

September 30, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    87 shares
    Share 35 Tweet 22
  • Physicists Develop Visible Time Crystal for the First Time

    73 shares
    Share 29 Tweet 18
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    59 shares
    Share 24 Tweet 15
  • Scientists Discover and Synthesize Active Compound in Magic Mushrooms Again

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Newly Launched BIRDBASE Dataset Monitors Ecological Traits of 11,000 Bird Species

Pellino Ubiquitin Ligases: Dual Roles in Blood Cancers

WGCNA and ceRNA Illuminate Bovine Fat Deposition

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.